Le Lézard
Classified in: Science and technology
Subjects: CCA, FVT

Akamai Technologies To Hold First Quarter 2024 Investor Conference Call On Thursday, May 9, at 4:30 PM ET


CAMBRIDGE, Mass., April 11, 2024 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, announced today that the company will hold a conference call for investors on Thursday, May 9, 2024, at 4:30 p.m. ET. The call will include the company's first quarter 2024 financial results and may include forward-looking financial guidance from management. The call will also be broadcast live via the internet at Akamai's Investor Relations page.

The live dial-in information for the conference call is:

In addition, a replay of the call will be available for two weeks following the conference by calling (877) 344-7529 (or (412) 317-0088 for international calls) and using Conference ID: 6371585. The archived webcast of this event may be accessed through the Akamai website.

About Akamai
Akamai powers and protects life online. Leading companies worldwide choose Akamai to build, deliver, and secure their digital experiences ? helping billions of people live, work, and play every day. Akamai Connected Cloud, a massively distributed edge and cloud platform, puts apps and experiences closer to users and keeps threats farther away. Learn more about Akamai's security, compute, and delivery solutions at akamai.com and akamai.com/blog, or follow Akamai Technologies on X, formerly Twitter and LinkedIn.

Contacts:
Gina Sorice                                                                                           
Media Relations                                                                                   
646-320-4107                                                                                     
[email protected]                                                                          

Mark Stoutenberg
Investor Relations
857-227-4491
[email protected]

 

SOURCE Akamai Technologies, Inc.


These press releases may also interest you

at 22:05
KRAFTON Achieves Record-high Sales of 665.9 billion KRW in 1Q24
KRAFTON Inc. (CEO CH Kim, KRX: 259960) announced its 1Q24 preliminary earnings on May 8. KRAFTON recorded its 1Q24 sales of 665.9B South Korean Won, Operating Profit (OP) of 310.5B KRW, and Net Profit (NP) of 348.6B KRW following the Korean...

at 22:00
vivo Announces Android 15 Beta Program for Developers on X100 and iQOO 12 Smartphones
vivo today announced the release of the Android 15 Beta Program for X100 and iQOO 12 smartphones in selected countries and regions. Starting from May 15, 2024, vivo developers will get early access to test and adapt their applications for the next...

at 22:00
TECNO Launches Shot On CAMON Contest Empowering Consumers to Find Their Creativity with Every Shot
Innovative technology brand TECNO today officially launched the Shot On CAMON Contest, its first-ever global photography contest. Using the hashtag #ShotOnCAMON, the competition invites TECNO users around the world to capture and share life's...

at 21:58
Poulterra Revolutionizes Poultry Industry with Launch of Innovative Manure-as-a-Service Platform
Today, Poulterra launches its Manure-as-a-Service ("MaaS") platform, an entirely new approach to reducing emissions across the poultry supply chain, while...

at 21:30
Rogers-O'Brien Construction Named Winner in the Mid-Sized Business Category of Fast Company's 2024 World Changing Ideas Awards
Fast Company's 2024 World Changing Ideas Awards winners were announced today. The Texas-based, family-owned general contractor is...

at 21:13
Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.00 per ADS and (ii) the Outstanding Ordinary Shares for a Purchase Price of 0.76 DKK per Ordinary Share
Mason Capital Management LLC, a Delaware limited liability company ("Mason Capital"), announced today that it has commenced a tender offer (the "Tender Offer") for any and all the outstanding ADSs and Ordinary Shares in Forward Pharma A/S (the...

More news about Science and technology...


News published on and distributed by: